SCHEMBL7429893

SCHEMBL7429893

Cc1cccc(C(=O)Cl)c1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.55
MYC P01106 1/20 0.53
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
RPA1 P27694 1/20 0.44
MCL1 Q07820 1/20 0.44
FABP3 P05413 2/20 0.43
ALOX15 P16050 1/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
KMT2A Q03164 2/20 0.42
HNF4A P41235 1/20 0.42
POLB P06746 1/20 0.41
CASP1 P29466 1/20 0.41
FABP5 Q01469 1/20 0.41
FGFR1 P11362 1/20 0.40
FGFR2 P21802 1/20 0.40
FGFR4 P22455 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10718417 0.86 ALDH1A1 (0.50) FABP4ALDH1A1HPGDKDM4EFABP3
SCHEMBL29563004 0.86 MYC (0.52) FABP4MYCALDH1A1HPGDKDM4E
SCHEMBL7907581 0.86 NPC1 (0.44) FABP4MYCALDH1A1KDM4EALOX15
SCHEMBL4363981 0.85 FABP4 (0.68) FABP4MYCALDH1A1HPGDKDM4E
SCHEMBL28409589 0.85 FABP4 (0.58) FABP4MYCALDH1A1HPGDKDM4E
Hydrochloric Acid SCHEMBL7605502 0.83 FABP4 (0.66) FABP4MYCALDH1A1HPGDKDM4E
SCHEMBL530286 0.83 FABP4 (0.57) FABP4MYCALDH1A1HPGDKDM4E
SCHEMBL7427762 0.81 MAPT (0.44) FABP4ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL4390271 0.80 SMO (0.47)
SCHEMBL776999 0.80 FABP4 (0.54) FABP4MYCALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 US disclosed
EP-1183239-A1 AROMATIC SULFONE HYDROXAMIC ACID METALLOPROTEASE INHIBITOR G.D. SEARLE & CO. (US) 2002-03-06 EP disclosed
WO-2000069821-A1 AROMATIC SULFONE HYDROXAMIC ACID METALLOPROTEASE INHIBITOR G.D. SEARLE & CO. (US) 2000-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 FABP4 13/4885MYC 4717/4885ALDH1A1 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.